Monitor first-day trading volume and price action for ODTX on May 8, 2026. The upsized IPO and TPG participation signal strong demand, but as a clinical-stage biotech with no approved products, near-term volatility is expected. Watch for pipeline updates and clinical data readouts as key catalysts.
Price Chart
Executive Summary
Odyssey Therapeutics priced its upsized IPO of 15.5M shares at $18.00/share, with a concurrent private placement of 1.39M shares to a TPG affiliate, raising ~$304M in gross proceeds. The stock begins trading on Nasdaq on May 8, 2026, providing the company with capital to advance its autoimmune/inflammatory disease pipeline.
Key Financial Metrics
Key Facts
- IPO of 15,500,000 shares at $18.00 per share, upsized from initial terms
- Concurrent private placement of 1,388,889 shares to TPG Life Sciences Innovations at same $18.00 price
- Gross proceeds expected to be ~$304 million before expenses
- Underwriters have 30-day option to purchase up to 2,325,000 additional shares
- Common stock to trade on Nasdaq Capital Market under ticker ODTX starting May 8, 2026
- Offering expected to close on or about May 11, 2026
- J.P. Morgan, TD Cowen, and Cantor acting as joint book-running managers
Financial Impact
Gross proceeds of ~$304 million from IPO and concurrent private placement
Risk Factors
- Clinical-stage biotech with no approved products; pipeline failure risk
- Dilution from IPO and potential additional share sales via underwriter option
- Forward-looking statements subject to regulatory and clinical trial uncertainties
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3290782 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $18.99 $19.00 | ▲ +0.05% | ▼ −0.47% | $19.30 (+1.63%) |
Aug 4, 2026 11w ago | 8-K | $19.96 $20.89 | ▲ +4.66% | ▲ +4.86% | $19.30 (−3.31%) |
Jun 17, 2026 18w ago | 8-K | $19.07 $18.72 | ▼ −1.84% | ▼ −1.52% | $19.30 (+1.21%) |
May 11, 2026 24w ago | Insider Cluster | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.30 (+10.60%) |
May 8, 2026 24w ago | 424B4 | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.30 (+10.60%) |
May 8, 2026 24w ago | EFFECT | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers